- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-HMGA2
HMGA2 Polyclonal Antibody for WB, IP, IF, IHC, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IHC, IF/ICC, IP, CoIP, ELISA
Conjugaison
Non conjugué
N° de cat : 20795-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules A549, cellules C6, cellules HCT 116, cellules HepG2, cellules NCI-H1299, cellules NIH/3T3 |
Résultats positifs en IP | cellules NIH/3T3 |
Résultats positifs en IHC | tissu de cancer du pancréas humain, tissu de cancer du côlon humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
Résultats positifs en IF/ICC | cellules A549, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochimie (IHC) | IHC : 1:250-1:1000 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 6 publications below |
WB | See 30 publications below |
IHC | See 6 publications below |
IF | See 3 publications below |
IP | See 1 publications below |
CoIP | See 3 publications below |
Informations sur le produit
20795-1-AP cible HMGA2 dans les applications de WB, IHC, IF/ICC, IP, CoIP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Réactivité citée | rat, Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | HMGA2 Protéine recombinante Ag14588 |
Nom complet | high mobility group AT-hook 2 |
Masse moléculaire calculée | 108 aa, 12 kDa |
Poids moléculaire observé | 18-20 kDa |
Numéro d’acquisition GenBank | NM_003483 |
Symbole du gène | HMGA2 |
Identification du gène (NCBI) | 8091 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
HMGA2 belongs to the family of high mobility group with AT-hook DNA binding domain. HMGA proteins are considered architectural transcription factors; they do not have direct transcriptional activation capacity, but instead regulate gene expression by changing DNA conformation through binding to AT-rich regions in the DNA and/or direct interaction with other transcription factors (PMID: 18202751,19551524). HMGA2 is abundantly and ubiquitously expressed and plays a crucial role during embryonic development (18425117). HMGA2 promotes stem cell self-renewal and research studies have shown that decreased HMGA2 expression is associated with stem cell aging (19551524). Investigators have shown that expression levels of HMGA2 are very low in normal adult tissues, while either overexpression or rearrangement is associated with many types of cancer (PMID: 20228781). The calcualted molecular weight of HMGA2 is 12 kDa, but modified HMGA2 is about 18-20 kDa. (PMID: 18505920 )
Protocole
Product Specific Protocols | |
---|---|
WB protocol for HMGA2 antibody 20795-1-AP | Download protocol |
IHC protocol for HMGA2 antibody 20795-1-AP | Download protocol |
IF protocol for HMGA2 antibody 20795-1-AP | Download protocol |
IP protocol for HMGA2 antibody 20795-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Nat Commun ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer. | ||
Nat Commun N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. | ||
Cancer Res Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial-Mesenchymal Transition | ||
ACS Appl Mater Interfaces Layered Double Hydroxide Nanoparticles with Osteogenic Effects as miRNA Carriers to Synergistically Promote Osteogenesis of MSCs. | ||
J Hematol Oncol MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC. |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Balawant (Verified Customer) (07-25-2022) | this is very excellent antibody, I have used and it is working great. I will recumbent this antibody if you want for immunoblotting.
|
FH Susmita (Verified Customer) (04-13-2022) | This antibody is working fine for my WB
|
FH Iram (Verified Customer) (09-17-2020) | HMGA2 bands are very clear and sharp bands.
|